EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beyond the Liver: Diuretic-Induced Hyperammonemia in Patients Without Cirrhosis: A Case Series

Ashish D. Rajput, Priyanka R. Diwan, Sapna D. Gupta, Supriya D. Malhotra

Pharmacology and Toxicology Research · 05.11.2026 · 2 · 71-75

DOI: 10.68163/ptr.2026.73 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology and Toxicology Research, online erschienen am 05.11.2026. Verfasst von Ashish D. Rajput und 3 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective: Hyperammonemic encephalopathy is conventionally attributed to hepatic failure, inherited urea-cycle defects, or portosystemic shunting. Diuretic therapy, widely used for hypertension, heart failure and fluid overload, is a less recognized trigger that can increase serum ammonia levels through mechanisms unrelated to the severity of underlying liver disease. We describe three such cases and examine their implications for clinical recognition. Materials and Methods: We conducted a retrospective review of three patients who developed hyperammonemia temporally associated with diuretic therapy, identified through pharmacovigilance reporting and clinical evaluation.

Results

We report three elderly women, aged 68-72 years, with hypertension and cardiometabolic comorbidities but no documented chronic liver disease, who developed hyperammonemia temporally associated with diuretic use. The implicated regimens included a combination of hydrochlorothiazide, torsemide and spironolactone; spironolactone monotherapy and torsemide monotherapy. Clinical presentations varied widely, ranging from altered sensorium accompanied by diarrhea and generalized weakness, to progressive breathlessness with pedal edema, to sudden eyelid myoclonus with high-grade fever, none of which was initially suggestive of hyperammonemia. Serum ammonia concentrations ranged from 110 to 153 mcg/dL. Two patients recovered following diuretic withdrawal, whereas the third did not survive despite similar management.

Conclusion

Diuretic-induced hyperammonemia is not restricted to loop or thiazide diuretics and can occur with potassium-sparing therapy alone. A low threshold for ammonia testing may therefore be warranted in diuretic-treated patients presenting with unexplained neurological, respiratory, or systemic symptoms, irrespective of hepatic status.

Zitieren

APA

Rajput, A. D., Diwan, P. R., Gupta, S. D., & Malhotra, S. D. (2026). Beyond the Liver: Diuretic-Induced Hyperammonemia in Patients Without Cirrhosis: A Case Series. Pharmacology and Toxicology Research, 2, 71-75. https://doi.org/10.68163/ptr.2026.73

Vancouver

Rajput AD, Diwan PR, Gupta SD, Malhotra SD. Beyond the Liver: Diuretic-Induced Hyperammonemia in Patients Without Cirrhosis: A Case Series. Pharmacology and Toxicology Research. 2026;2:71-75. doi:10.68163/ptr.2026.73

BibTeX
@article{Rajput2026,
  author = {Rajput, Ashish D. and Diwan, Priyanka R. and Gupta, Sapna D. and Malhotra, Supriya D.},
  title = {Beyond the Liver: Diuretic-Induced Hyperammonemia in Patients Without Cirrhosis: A Case Series},
  journal = {Pharmacology and Toxicology Research},
  year = {2026},
  volume = {2},
  pages = {71--75},
  doi = {10.68163/ptr.2026.73}
}
Kostenlos starten →